Funder: National Institutes of Health
Due Dates: February 16, 2025 (New) | March 16, 2025 (Renewal/Resubmission/Revision) | May 7, 2025 (AIDS-related)
Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 in any single year; max project period: 3 years.
Summary: Supports Stage I research to develop, refine, and pilot-test behavioral and integrative interventions for substance use disorders, HIV prevention, chronic pain, and treatment adherence.
Key Information: Only Stage I behavioral intervention development is supported; alcohol use disorder as a primary outcome is not eligible.